The Board of Directors of the Company at its meeting held today February 9 2022 has inter alia considered and approved a Third Interim Dividend @ 150% i.e. Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2021-22. The Company has fixed February 21 2022 as the Record Date for the purpose of payment of Third Interim Dividend and the same will be paid on or before March 4 2022.
Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Dividend Updates
February 9, 2022
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month